Ramsay Générale de Santé SA Financials

Market Capitalization €1.01 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	35.68
Forward PE
Price to Sales TTM	€0.19
Price to Book MRQ	€0.88
Enterprise to Revenue	0.91
Enterprise to EBITDA	13.43

Financial Reports as of Dec. 31, 2014

Financials

Fiscal Year Ends	2025-06-30
Most Recent Quarter	2014-12-31
Profit Margin	-1.03%
Operating Margin	3.61%
Return on Assets TTM	1.72%
Return on Equity TTM	-2.90%

Income Statement

Revenue TTM	€5,241,999,872
Revenue per Share TTM	€47.50
Quarterly Revenue Growth	-39.47%
Gross Profit TTM	€1,428,000,000
EBITDA	€215,400,000
Net Income to Common TTM	€-51,000,000
Diluted EPS TTM	€-0.46
Quarterly Earnings Growth YoY	-33.60%

Balance Sheet

Total Cash MRQ	€366,500,000
Total Cash per Share MRQ	€3.32
Total Debt MRQ	€
Total Debt to Equity MRQ	343.66
Current Ratio MRQ	0.80
Book Value per Share MRQ	€10.38

Cash Flow

Operating Cash Flow TTM	€693,699,968
Levered Free Cash Flow TTM	€409,849,984

GD6 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	110,362,392
Float Shares	771,482
Avg 10 Volume	265
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.47%
% Held by Institutions	39.92%

Stock Price Summary

Beta	0.12
Fifty Two Week Low	€8.68
Fifty Two Week High	€12.65
Fifty Two Week Change	-35.67%
Day 50 MA	€8.87
Day 200 MA	€9.76

Dividends and Splits

Forward Annual Dividend Rate	€6.02
Forward Annual Dividend Yield	65.85%
Trailing Annual Dividend Rate	€1.50
Trailing Annual Dividend Yield	16.46%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2014-12-02
Last Split Factor
Last Split Date